GABRG2 and in situ carcinoma: However, the mRNA level of GABRG2 in the middle-aged CIS group was decreased significantly compared with that in the young CIS group (Fig. 3b, P < 0.05) and the middle-aged control group (Fig. 3b, P < 0.05).